September 7, 2023 General information Moderna Says Its New COVID-19 Vaccine Protects Against the BA.2.86 Variant
April 29, 2022 Pediatrics Moderna applies to FDA and Health Canada for COVID vaccine approval for children under six. It will be scrutinized and approval is not a slam-dunk as Pfizer experienced with its application (that it subsequently withdrew).
April 20, 2022 Vaccines Moderna reports on successful development of variant-specific updates to its vaccine.
January 7, 2022 Epidemiology Moderna CEO states fourth/yearly booster may be needed. We need credible independent sources to review the evidence to determine if cellular immunity will provide longer term protection mitigating booster frequency.
November 17, 2021 Clinical Research Moderna submits data to Health Canada for approval of its COVID-19 vaccine for children. Expect approval within weeks. I review with @billcarrolltalk why the dose is one-half of the adult version. #VaccinesWork
October 7, 2021 Epidemiology Sweden suspends Moderna vaccine but keeps Pfizer for under 30’s citing unpublished nor peer reviewed data on the “very small” risk of vaccine-induced myocarditis. Previous research reported COVID poses 5-10 times greater risk than vaccine.
September 27, 2021 Clinical Research Retracted Canadian study that reported 1/1000 risk of myocarditis from mRNA vaccine weaponized by anti-vaccination websites despite data correction by the authors to 1/25,000. Review system worked to uncover error but damage now done.
September 1, 2021 Health Headlines Moderna vs Pfizer antibody titre study cannot answer if it leads to differences in cellular immunity, protection against variants, duration, risks of transmission or clinical outcomes. Real world data shows they both work equally well. #vaccineswork
June 29, 2021 Allergy/Immunology Much ado about coffee (another observational study about it, please make it stop) with apologies to the Bard. Let’s move on to a more relevant study that shows mRNA vaccines produce long-term persistent immunity. #VaccinesWork